Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B Jr, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O’Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stüve O, Waubant E, Polman CH (2014) Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83(3):278–286. https://doi.org/10.1212/WNL.0000000000000560
Rice CM, Cottrell D, Wilkins A, Scolding NJ (2013) Primary progressive multiple sclerosis: progress and challenges. J Neurol Neurosurg Psychiatry 84(10):1100–1106. https://doi.org/10.1136/jnnp-2012-304140
Antel J, Antel S, Caramanos Z, Arnold DL, Kuhlmann T (2012) Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity? Acta Neuropathol 123(5):627–638. https://doi.org/10.1007/s00401-012-0953-0
Miller DH, Leary SM (2007) Primary-progressive multiple sclerosis. Lancet Neurol 6(10):903–912. https://doi.org/10.1016/S1474-4422(07)70243-0. (Erratum in: Lancet Neurol 2009;8(8):699.)
Ebers GC (2004) Natural history of primary progressive multiple sclerosis. Mult Scler 10(1):S8–S13. https://doi.org/10.1191/1352458504ms1025oa
Koch M, Kingwell E, Rieckmann P, Tremlett H (2009) The natural history of primary progressive multiple sclerosis. Neurology 73(23):1996–2002. https://doi.org/10.1212/WNL.0b013e3181c5b47f
Harding KE, Wardle M, Moore P, Tomassini V, Pickersgill T, Ben-Shlomo Y, Robertson NP (2015) Modelling the natural history of primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 86(1):13–19. https://doi.org/10.1136/jnnp-2014-307791
Confavreux C, Vukusic S (2006) Natural history of multiple sclerosis: a unifying concept. Brain 129(3):606–616. https://doi.org/10.1093/brain/awl007
Wilkins A (2017) Progressive multiple sclerosis, 2nd edn. Springer, Cham. https://doi.org/10.1007/978-3-319-65921-3
Amezcua L (2022) Progressive multiple sclerosis. Continuum Minneap Minn 28(4):1083–1103. https://doi.org/10.1212/CON.0000000000001157
Tremlett H, Paty D, Devonshire V (2005) The natural history of primary progressive MS in British Columbia, Canada. Neurology 65(12):1919–1923
Koch M, Mostert J, Heersema D, De Keyser J (2007) Progression in multiple sclerosis: further evidence of an age dependent process. J Neurol Sci 255(1–2):35–41
Article CAS PubMed Google Scholar
Holland NJ, Schneider DM, Rapp R, Kalb RC (2011) Meeting the needs of people with primary progressive multiple sclerosis, their families, and the health-care community. Int J MS Care 13(2):65–74
Article PubMed PubMed Central Google Scholar
Hay M, Rollot F, Casey R, Kerbrat A, Edan G, Mathey G, Labauge P, De Sèze J, Vukusic S, Laplaud DA, Papeix C, Moreau T, Thouvenot E, Defer G, Lebrun-Frénay C, Ciron J, Berger E, Stankoff B, Clavelou P, Maillart E, Heinzlef O, Zéphir H, Ruet A, Casez O, Moulin S, Al-Khedr A, Bourre B, Pelletier J, Magy L, Neau JP, Camdessanché JP, Doghri I, Wahab A, Tchikviladzé M, Labeyrie C, Hankiewicz K, Le Page E, Michel L, OFSEP Investigators (2024) Anti-CD20 therapies in drug-naive patients with primary progressive multiple sclerosis: a multicenter real-life study. Neurology 103(8):e209886. https://doi.org/10.1212/WNL.0000000000209886
Fraser C, Polito S (2007) A comparative study of self-efficacy in men and women with multiple sclerosis. J Neurosci Nurs 39(2):102–106
Salter A, Thomas NP, Tyry T, Cutter GR (2018) A contemporary profile of primary progressive multiple sclerosis participants from the NARCOMS Registry. Mult Scler 24(7):951–962. https://doi.org/10.1177/1352458517711274
Bogosian A, Day F, Norton S, Silber E, Sakel M, Sharrack B, Moss-Morris R (2022) Key demographics and psychological skills associated with adjustment to progressive Multiple Sclerosis early in the diagnosis. Front Rehabil Sci 3:966133
Article PubMed PubMed Central Google Scholar
Blinkenberg M, Kjellberg J, Ibsen R, Magyari M (2020) Increased socioeconomic burden in patients with primary progressive multiple sclerosis: A Danish nationwide population-based study. Mult Scler Relat Disord 46:102567
Article CAS PubMed Google Scholar
Purmonen T, Hakkarainen T, Tervomaa M, Ruutiainen J (2020) Impact of multiple sclerosis phenotypes on burden of disease in Finland. J Med Econ 23(2):156–165
Pérez-Miralles F, Prefasi D, García-Merino A, Ara JR, Izquierdo G, Meca-Lallana V, Gascón F, Martínez-Ginés ML, Ramió-Torrentà L, Costa-Frossard L, Fernández Ó, Moreno-García S, Maurino J, Casanova-Estruch B (2019) Perception of stigma in patients with primary progressive multiple sclerosis. Mult Scler J 5(2):2055217319852717
Maurino J, Martínez-Ginés ML, García-Domínguez JM, Solar MD, Carcelén-Gadea M, Ares-Luque A, Ballabriga J, Navarro-Cantó L, Medrano N, Honan CA, W-IMPACT Study Group (2020) Workplace difficulties, health-related quality of life, and perception of stigma from the perspective of patients with multiple sclerosis. Mult Scler Relat Disord 41:102046. https://doi.org/10.1016/j.msard.2020.102046
Fox RJ, Thompson A, Baker D, Baneke P, Brown D, Browne P, Chandraratna D, Ciccarelli O, Coetzee T, Comi G, Feinstein A, Kapoor R, Lee K, Salvetti M, Sharrock K, Toosy A, Zaratin P, Zuidwijk K (2012) Setting a research agenda for progressive multiple sclerosis: the International Collaborative on Progressive MS. Mult Scler 18(11):1534–1540. https://doi.org/10.1177/1352458512458169
Article PubMed PubMed Central Google Scholar
Zackowski KM, Freeman J, Brichetto G, Centonze D, Dalgas U, DeLuca J, Ehde D, Elgott S, Fanning V, Feys P, Finlayson M, Gold SM, Inglese M, Marrie RA, Ploughman M, Sang CN, Sastre-Garriga J, Sincock C, Strum J, van Beek J, Feinstein A (2021) Prioritizing progressive MS rehabilitation research: a call from the International Progressive MS Alliance. Mult Scler 27(7):989–1001. https://doi.org/10.1177/1352458521999970
Article PubMed PubMed Central Google Scholar
Arksey H, O’Malley L (2005) Scoping studies: towards a methodological framework. Int J Soc Res Methodol 8:19–32
Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Godfrey CM, Macdonald MT, Langlois EV, Soares-Weiser K, Moriarty J, Clifford T, Tunçalp Ö, Straus SE (2018) PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 169(7):467–473. https://doi.org/10.7326/M18-0850
Wright J, Williams R, Wilkinson JR (1998) Development and importance of health needs assessment. BMJ 316(7140):1310–1313. https://doi.org/10.1136/bmj.316.7140.1310
Article CAS PubMed PubMed Central Google Scholar
Luxford K (2012) What does the patient know about quality? Int J Qual Health Care 24(5):439–440. https://doi.org/10.1093/intqhc/mzs053
Ahmed F, Burt J, Roland M (2014) Measuring patient experience: concepts and methods. Patient 7(3):235–241. https://doi.org/10.1007/s40271-014-0060-5
Borkman T (1976) Experiential knowledge: a new concept for the analysis of self-help groups. Soc Serv Rev 50(3):445–456. https://doi.org/10.1086/643401
Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, McInerney P, Godfrey CM, Khalil H (2020) Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth 18(10):2119–2126. https://doi.org/10.11124/JBIES-20-00167
Critical Appraisal Skills Programme (2018) CASP Qualitative checklist. https://casp-uk.net. Accessed 15 June 2025
Hong QN et al (2018) Mixed methods appraisal tool (MMAT) version 2018. http://mixedmethodsappraisaltoolpublic.pbworks.com. Accessed 15 June 2025
Frost J, Grose J, Britten N (2017) A qualitative investigation of lay perspectives of diagnosis and self-management strategies employed by people with progressive multiple sclerosis. Health (London) 21(3):316–336. https://doi.org/10.1177/1363459316674787
Bogosian A, Morgan M, Bishop FL, Day F
Comments (0)